Premium
Safety and efficacy of a combination of paromomycin and miltefosine for two vs. three courses in patients with post‐kala‐azar dermal leishmaniasis: an observational pilot study
Author(s) -
Pandey K.,
Pal B.,
Das V.N.R.,
Murti K.,
Lal C.S.,
Verma N.,
Bimal S.,
Ali V.,
Verma R.B.,
Topno R.K.,
Siddiqi N.A.,
Das P.
Publication year - 2017
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.15119
Subject(s) - miltefosine , paromomycin , visceral leishmaniasis , leishmania donovani , leishmaniasis , medicine , dermatology , amphotericin b , pharmacology , immunology , antibiotics , biology , aminoglycoside , antifungal , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom